Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-020480

EVP & Chief Financial Officer disposed of 2,500 shares (other)

  • EVP & Chief Financial Officer acquired 2,500 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Byrne Jason EVP & Chief Financial Officer 2026-03-20 Other disposition −2,500 160,115 D
O'Byrne Jason EVP & Chief Financial Officer 2026-03-20 Other acquisition +2,500 2,500 I
Loading xslF345X06/wk-form4_1774295389.xml…